is retatrutide a triple agonist triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing Eli Lilly and Company's triple
Pay in 4 interest-free payments of $5.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26










:max_bytes(150000):strip_icc()/26Q1_WL_oral-sema_newsroom_1920x1008-1dfa18327b724266bed50c36ab0b9d49.jpg)










![[Master Tailoring] LILY Structured Shoulder Blazer size:M](https://cdn.shopify.com/s/files/1/0659/3151/0018/files/126140C2131_126120C7122_126120TK320_126120GJ928-2_4362d790-db30-4dd1-aa17-4709afd94198.webp?v=1782811604)




